Patrick G. Enright, Director at Jazz Pharmaceuticals plc (JAZZ), sold 14,775 shares at $145.81 ($2.2M) on 2020-11-12, disclosed to the SEC on 2020-11-13.
Open-market sale of $2.2M JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $145.81 | 3,223 | $470K | 21.7% |
| 2 | $145.81 | 3,223 | $470K | 21.7% |
| 3 | $147.00 | 5,083 | $747K | 34.5% |
| 4 | $147.61 | 1,623 | $240K | 11.1% |
| 5 | $147.61 | 1,623 | $240K | 11.1% |
| Total | $146.61 avg | 14,775 |
| $2.2M |
| 100% |
| Filing → |
| ZBIO | BUY | 2025-10-14 | $2.5M | — | Filing → |
| VERA | BUY | 2025-06-25 | $10.6M | — | Filing → |
| BIOA | BUY | 2024-09-27 | $7.2M | — | Filing → |